Review clinical trials related to Lung Cancer (SCLC). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.
This prospective study aims to develop a multi-omics-based predictive model for radiation pneumonitis in lung cancer patients receiving sequential immunotherapy and thoracic radiotherapy.
Not listed
This is clinical trial evaluating the safety and efficacy of radiotherapy combined with immunotherapy and chemotherapy in patients with extensive-stage small-cell lung cancer (ES-SCLC) and liver metastases.
Aged 18 to 75 years, with an ECOG Performance Status of 0-2. [+11]
Presence of any active autoimmune disease or a history of autoimmune diseases (s... [+9]
The objective of this study is to construct a noninvasive approach using radiolabbled peptide 68Ga-cPP-BCH PET/CT to detect the PD-L1 expression of tumor lesion in patients with lung cancer, melanoma and other solid tumor to identify patients benefiting from anti-PD-(L)1 treatment.
Aged 18-75, male and female, with ECOG score of 0 or 1; [+6]
The function of liver and kidney was seriously abnormal; [+4]